1-4 of 4
Mauricio Urquiza, PhD
Close
Sort by
Journal Articles

Ad-ISF35 Intratumoral Administration Induces a Bystander Effect and Immune-Mediated Tumor Rejection with a Safe Vector Biodistribution and Toxicology Profile In a NHL Mouse Model.

Johanna Melo-Cardenas, B.Sc, Mauricio Urquiza, PhD, Robier Aguillon-Prada, M.D, Thomas J. Kipps, MD, PhD, Januario E Castro, M.D
Journal: Blood
Blood (2010) 116 (21): 1470.
https://doi.org/10.1182/blood.V116.21.1470.1470
Published: 2010
Journal Articles

Ad-ISF35- Transduced Autologous Cells Promote In Vitro and In Vivo Chemosensitization to FCR and Durable Complete Responses In Patients with Del(17p)/P53 Defective Chronic Lymphocytic Leukemia.

Januario E Castro, M.D, Johanna Melo-Cardenas, B.Sc, Juan Sebastian Barajas-Gamboa, M.D, Mauricio Urquiza, PhD, Mark J. Cantwell, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1472.
https://doi.org/10.1182/blood.V116.21.1472.1472
Published: 2010
Journal Articles

Immune Gene Therapy for Patients with CLL Using Repeat Dose Intranodal Injection of Ad-ISF35, a Replication Incompetent Vector Expressing a Membrane-Stable CD40 Binding Protein.

Januario E Castro, M.D, Johanna Melo-Cardenas, B.Sc, Juan Sebastian Barajas-Gamboa, M.D, Ramin Sean Pakbaz, M.D, Mauricio Urquiza, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1476.
https://doi.org/10.1182/blood.V116.21.1476.1476
Published: 2010
Journal Articles

A Phase I Study of Immune Gene Therapy for Patients with CLL Using Intranodal Injection of ISF35, a Membrane-Stable CD40 Binding Protein.

Januario Castro, MD, Jose D. Sandoval, MD, Johanna Melo-Cardenas, B.Sc, Denise Darrah, RN, Mauricio Urquiza, PhD, Charles Prussak, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2100.
https://doi.org/10.1182/blood.V112.11.2100.2100
Published: 2008